These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1837237)

  • 1. Exposure to low-frequency pulsed electromagnetic fields increases mitogen-induced lymphocyte proliferation in Down's syndrome.
    Cossarizza A; Monti D; Bersani F; Scarfi MR; Zanotti M; Cadossi R; Franceschi C
    Aging (Milano); 1991 Sep; 3(3):241-6. PubMed ID: 1837237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extremely low frequency pulsed electromagnetic fields increase cell proliferation in lymphocytes from young and aged subjects.
    Cossarizza A; Monti D; Bersani F; Cantini M; Cadossi R; Sacchi A; Franceschi C
    Biochem Biophys Res Commun; 1989 Apr; 160(2):692-8. PubMed ID: 2719691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing effect of lithium and potassium ions on lectin-induced lymphocyte proliferation in aging and Down's syndrome subjects.
    Licastro F; Chiricolo M; Tabacchi P; Barboni F; Zannotti M; Franceschi C
    Cell Immunol; 1983 Jan; 75(1):111-21. PubMed ID: 6297805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extremely low frequency pulsed electromagnetic fields increase interleukin-2 (IL-2) utilization and IL-2 receptor expression in mitogen-stimulated human lymphocytes from old subjects.
    Cossarizza A; Monti D; Bersani F; Paganelli R; Montagnani G; Cadossi R; Cantini M; Franceschi C
    FEBS Lett; 1989 May; 248(1-2):141-4. PubMed ID: 2785933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological features of Down's syndrome: a review.
    Nespoli L; Burgio GR; Ugazio AG; Maccario R
    J Intellect Disabil Res; 1993 Dec; 37 ( Pt 6)():543-51. PubMed ID: 8124000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell response to anti-CD3 antibody in Down's syndrome.
    Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
    Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome.
    Franceschi C; Licastro F; Chiricolo M; Bonetti F; Zannotti M; Fabris N; Mocchegiani E; Fantini MP; Paolucci P; Masi M
    J Immunol; 1981 Jun; 126(6):2161-4. PubMed ID: 6453157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages.
    Burgio GR; Ugazio AG; Nespoli L; Marcioni AF; Bottelli AM; Pasquali F
    Eur J Immunol; 1975 Sep; 5(9):600-3. PubMed ID: 11993318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down's syndrome.
    Park E; Alberti J; Mehta P; Dalton A; Sersen E; Schuller-Levis G
    Clin Immunol; 2000 Apr; 95(1 Pt 1):62-9. PubMed ID: 10794433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of decreased T-cell-mediated natural cytotoxicity and interferon production in Down's syndrome.
    Nair MP; Schwartz SA
    Clin Immunol Immunopathol; 1984 Dec; 33(3):412-24. PubMed ID: 6209046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
    Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
    J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered cellular immune functions in patients with Down's syndrome.
    Spina CA; Smith D; Korn E; Fahey JL; Grossman HJ
    Am J Dis Child; 1981 Mar; 135(3):251-5. PubMed ID: 6452055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trisomy 21 (Down's syndrome): autoimmunity, aging and monoclonal antibody-defined T-cell abnormalities.
    Rabinowe SL; Rubin IL; George KL; Adri MN; Eisenbarth GS
    J Autoimmun; 1989 Feb; 2(1):25-30. PubMed ID: 2526634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down's syndrome, aging, and Alzheimer's disease: a clinical review.
    Lott IT
    Ann N Y Acad Sci; 1982; 396():15-27. PubMed ID: 6217773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.
    Maccario R; Ugazio AG; Nespoli L; Alberini C; Montagna D; Porta F; Bonetti F; Burgio GR
    Clin Exp Immunol; 1984 Jul; 57(1):220-6. PubMed ID: 6235075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the capping phenomenon on lymphocytes from aged and Down's syndrome subjects.
    Chiricolo M; Minelli L; Licastro F; Tabacchi P; Zannotti M; Franceschi C
    Gerontology; 1984; 30(3):145-52. PubMed ID: 6233207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodeficiency and plasma zinc levels in children with Down's syndrome: a long-term follow-up of oral zinc supplementation.
    Stabile A; Pesaresi MA; Stabile AM; Pastore M; Sopo SM; Ricci R; Celestini E; Segni G
    Clin Immunol Immunopathol; 1991 Feb; 58(2):207-16. PubMed ID: 1824686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocytes in patients with Down's syndrome.
    Wisniewski K; Cobill JM; Wilcox CB; Caspary EA; Williams DG; Wisniewski HM
    Biol Psychiatry; 1979 Jun; 14(3):463-71. PubMed ID: 157786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down's syndrome: problems of immunodeficiency.
    Ugazio AG
    Hum Genet Suppl; 1981; 2():33-9. PubMed ID: 6218139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal thymic differentiation in Down's syndrome.
    Cossarizza A; Monti D; Montagnani G; Forabosco A; Dagna-Bricarelli F; Franceschi C
    Thymus; 1989; 14(1-3):163-70. PubMed ID: 2533759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.